BLOG

BioProcessOnline

ADC Executive Roundtable — Perfecting The Payload And Navigating The Regulatory Landscape

Philipp Spycher has an extensive background in bioconjugation and ADCs. He obtained his master’s degree and Ph.D. from ETH Zurich in material science and protein engineering. During his post-doctoral work at Paul Scherrer Institute, he introduced the novel approach of using transglutaminases for antibody conjugation, which led to the discovery of what is now called Araris linker technology.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}